journal article·2023-04-26

Depriving Tumor Cells of Ways to Metastasize: Ferroptosis Nanotherapy Blocks Both Hematogenous Metastasis and Lymphatic Metastasis

Rong Guo, Miao Deng, Jiaxin Li, Xuan He, Penghui He, Houqin Liu, Yunxia Ye, Ziyi Mo, Xuan He, Man Li, Qin He

Nano Letters· Volume 23· Issue 8
Publisher page

Abstract

Blood and lymph are two main pathways of tumor metastasis; however, hematogenous metastasis and lymphatic metastasis are difficult to inhibit simultaneously. Ferroptosis provides a new breakthrough for metastasis inhibition, but how to effectively trigger ferroptosis in tumor cells remains a major challenge. Metastatic tumor cells are prone to ferroptosis in blood, while they may be protected from ferroptosis in lymph. In this study, a nanoplatform DA/RSL3 was constructed for the intracellular codelivery of the polyunsaturated arachidonic acid (AA) and the GPX4 inhibitor RSL3, which could not only induce ferroptosis but also alleviate ferroptosis resistance. As a result, DA/RSL3 effectively triggered ferroptosis in tumor cells, thereby impairing the ability of tumor cells to metastasize in both blood and lymph. Furthermore, a fucoidan blocking strategy was proposed to maximize the efficacy of DA/RSL3. Fu+DA/RSL3 showed excellent efficacy in 4T1 tumor-bearing mice. This ferroptosis nanotherapy is promising for metastatic cancer treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Epigenetics and DNA Methylation · Cancer, Lipids, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, Med-X Center for Materials, West China School of Pharmacy, Sichuan University, Chengdu 610041, China

Funding

Sichuan University · Department of Science and Technology of Sichuan Province · National Natural Science Foundation of China

References (28)

Show source-provided references
1. 10.1038/ncponc106610.1038/ncponc1066 ↗
2. 10.1038/nrc262210.1038/nrc2622 ↗
3. 10.1016/j.cell.2011.09.02410.1016/j.cell.2011.09.024 ↗
4. 10.1126/science.aai851510.1126/science.aai8515 ↗
5. 10.1126/science.aal366210.1126/science.aal3662 ↗
6. 10.1038/nm.339110.1038/nm.3391 ↗
7. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
8. 10.1038/s41580-020-00324-810.1038/s41580-020-00324-8 ↗
9. 10.1038/s41422-020-00441-110.1038/s41422-020-00441-1 ↗
10. 10.1038/s41568-022-00459-010.1038/s41568-022-00459-0 ↗
11. 10.1038/nature1572610.1038/nature15726 ↗
12. 10.1038/s41467-022-29018-910.1038/s41467-022-29018-9 ↗
13. 10.1038/s41586-020-2623-z10.1038/s41586-020-2623-z ↗
14. 10.1038/s41467-021-25354-410.1038/s41467-021-25354-4 ↗
15. 10.1038/nature0638510.1038/nature06385 ↗
16. 10.1126/science.aal362210.1126/science.aal3622 ↗
17. 10.1186/s12935-021-02057-w10.1186/s12935-021-02057-w ↗
18. 10.1016/j.apsb.2021.05.01210.1016/j.apsb.2021.05.012 ↗
19. 10.1021/acsnano.7b0673410.1021/acsnano.7b06734 ↗
20. 10.4049/jimmunol.100098910.4049/jimmunol.1000989 ↗
21. 10.1016/j.intimp.2019.10582310.1016/j.intimp.2019.105823 ↗
22. 10.1016/j.biomaterials.2017.11.04710.1016/j.biomaterials.2017.11.047 ↗
23. 10.1016/j.biomaterials.2018.12.02310.1016/j.biomaterials.2018.12.023 ↗
24. 10.1038/nrc300410.1038/nrc3004 ↗
25. 10.1182/blood-2014-08-53158210.1182/blood-2014-08-531582 ↗
26. 10.1126/scitranslmed.aaf737410.1126/scitranslmed.aaf7374 ↗
27. 10.1021/acs.nanolett.9b0388310.1021/acs.nanolett.9b03883 ↗
28. 10.1186/s13058-015-0558-310.1186/s13058-015-0558-3 ↗